Andrew Marderstein

@amarderstein.bsky.social

Human geneticist at MSK. Prev. postdoc at Stanford and BS + PhD at Cornell. avid skier, runner, and Yankee fan.

Our latest research is out today on ‪@medrxivpreprint.bsky.social: www.medrxiv.org/content/10.1... Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk. Led by the amazing Phoebe Dace. This one’s packed full of data, so check out the paper. Quick highlights… 🧵 1/n

Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk

Germline pathogenic BRCA1 variants predispose women to breast and ovarian cancer. Despite accumulation of functional evidence for variants in BRCA1 , over half of reported single-nucleotide variants (...

medrxiv.org

This was a really fun collaboration with @amarderstein.bsky.social where we explored some of the interesting relationships between context-specific non-coding variant effects, disease, and evolution using deep learning models of chromatin accessibility in the brain and heart.

Andrew Marderstein@amarderstein.bsky.social · last yr.

New preprint w/ @soumyakundu.bsky.social @sbmontgom.bsky.social @anshulkundaje.bsky.social ! Using deep learning & scATAC-seq, we studied context-specific variants in disease & evolution, and introduce FLARE for de novo mutations—w/ application to autism-affected families. doi.org/10.1101/2025...

Submissions for ASHG 2025’s Featured Symposium are due Feb 10 at 5:00 pm ET! Let me know if you have any questions. We're excited to see a wide range of proposals, ranging from AI/ML applications, clinical genetics, women's health, and more. www.ashg.org/meetings/202...

Featured Symposia

ASHG’s Featured Symposium are a part of the most premier science at the Annual Meeting, featuring 8,000 of the world’s leading geneticists. Questions: programs@ashg.org Looking to make your mark on th...

ashg.org